Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psychosis with Neurosyphilis

Introduction: Patients with neurosyphilis may present with severe neuropsychiatric sequelae which do not respond adequately even to clozapine which is regarded as the most efficacious medication for the treatment of schizophrenia. Clozapine augmentation with electroconvulsive therapy (ECT) has bee...

Descripció completa

Dades bibliogràfiques
Autors principals: Othman, Zahiruddin, Nordin, Muhammad Farhan
Format: Article
Idioma:English
Publicat: Japan International Cultural Exchange Foundation 2018
Matèries:
Accés en línia:http://eprints.usm.my/45299/1/224-16Othman.pdf
_version_ 1825835125534883840
author Othman, Zahiruddin
Nordin, Muhammad Farhan
author_facet Othman, Zahiruddin
Nordin, Muhammad Farhan
author_sort Othman, Zahiruddin
collection USM
description Introduction: Patients with neurosyphilis may present with severe neuropsychiatric sequelae which do not respond adequately even to clozapine which is regarded as the most efficacious medication for the treatment of schizophrenia. Clozapine augmentation with electroconvulsive therapy (ECT) has been shown to be an effective and safe treatment strategy for treatment-resistant schizophrenia. Objective: This case report aimed to describe a patient with neurosyphilis, whose psychotic symptoms did not improve significantly although he had multiple adequate medication trials including daily doses of fluoxetine 40 mg, olanzapine 15 mg, haloperidol 15 mg, sulpiride 1,000 mg, quetiapine 800 mg, and finally clozapine 150 mg. Result: The patient was stabilized with a combination of clozapine and maintenance ECT. A total of no less than 120 sessions of ECT (stimulus dose ranged 15-200% and seizure duration 8-57 seconds) were given by August 2017 while the clozapine was maintained at 75 mg bd. The patient had one episode of spontaneous seizure during induction of general anesthesia with etomidate. Otherwise, there was no documented serious adverse effect. Conclusion: Maintenance electroconvulsive therapy augmentation on clozapine-resistant psychosis with neurosyphilis is effective and safe but has never been reported in the literature to the authors' knowledge. It is hoped that this case report would contribute to the scarce literature on this augmentation strategy.
first_indexed 2024-03-06T15:33:03Z
format Article
id usm.eprints-45299
institution Universiti Sains Malaysia
language English
last_indexed 2024-03-06T15:33:03Z
publishDate 2018
publisher Japan International Cultural Exchange Foundation
record_format dspace
spelling usm.eprints-452992019-08-26T08:15:06Z http://eprints.usm.my/45299/ Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psychosis with Neurosyphilis Othman, Zahiruddin Nordin, Muhammad Farhan RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry Introduction: Patients with neurosyphilis may present with severe neuropsychiatric sequelae which do not respond adequately even to clozapine which is regarded as the most efficacious medication for the treatment of schizophrenia. Clozapine augmentation with electroconvulsive therapy (ECT) has been shown to be an effective and safe treatment strategy for treatment-resistant schizophrenia. Objective: This case report aimed to describe a patient with neurosyphilis, whose psychotic symptoms did not improve significantly although he had multiple adequate medication trials including daily doses of fluoxetine 40 mg, olanzapine 15 mg, haloperidol 15 mg, sulpiride 1,000 mg, quetiapine 800 mg, and finally clozapine 150 mg. Result: The patient was stabilized with a combination of clozapine and maintenance ECT. A total of no less than 120 sessions of ECT (stimulus dose ranged 15-200% and seizure duration 8-57 seconds) were given by August 2017 while the clozapine was maintained at 75 mg bd. The patient had one episode of spontaneous seizure during induction of general anesthesia with etomidate. Otherwise, there was no documented serious adverse effect. Conclusion: Maintenance electroconvulsive therapy augmentation on clozapine-resistant psychosis with neurosyphilis is effective and safe but has never been reported in the literature to the authors' knowledge. It is hoped that this case report would contribute to the scarce literature on this augmentation strategy. Japan International Cultural Exchange Foundation 2018-08 Article PeerReviewed application/pdf en http://eprints.usm.my/45299/1/224-16Othman.pdf Othman, Zahiruddin and Nordin, Muhammad Farhan (2018) Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psychosis with Neurosyphilis. International Medical Journal, 25 (4). pp. 224-225. ISSN 1341-2051 http://www.seronjihou.co.jp/IMJ/backnumber-IMJ.html
spellingShingle RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Othman, Zahiruddin
Nordin, Muhammad Farhan
Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psychosis with Neurosyphilis
title Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psychosis with Neurosyphilis
title_full Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psychosis with Neurosyphilis
title_fullStr Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psychosis with Neurosyphilis
title_full_unstemmed Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psychosis with Neurosyphilis
title_short Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psychosis with Neurosyphilis
title_sort maintenance electroconvulsive therapy augmentation on clozapine resistant psychosis with neurosyphilis
topic RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
url http://eprints.usm.my/45299/1/224-16Othman.pdf
work_keys_str_mv AT othmanzahiruddin maintenanceelectroconvulsivetherapyaugmentationonclozapineresistantpsychosiswithneurosyphilis
AT nordinmuhammadfarhan maintenanceelectroconvulsivetherapyaugmentationonclozapineresistantpsychosiswithneurosyphilis